A 12 Week, Multi-Center,Randomized, Double Blinded, Parallel Group, Placebo-Controlled, 4-Arm, Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma.
Phase of Trial: Phase II
Latest Information Update: 18 Dec 2013
At a glance
- Drugs SOTB 07 (Primary) ; Montelukast
- Indications Asthma
- Focus Therapeutic Use
- 23 Mar 2011 Planned end date changed from 1 Mar 2010 to 1 Oct 2011 as reported by ClinicalTrials.gov.
- 23 Mar 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 18 Jul 2009 New trial record